Abstract: Many risk factors have been firmly established for pancreatic cancer (PC), but the molecular processes by which known risk factors influence susceptibility to PC are not clear. There has been a recent upsurge of interest in the role of telomere length (TL), the protective DNA sequence repeats at chromosome ends, in pancreatic carcinogenesis. Given this heightened interest, we performed an in-depth, focused, and up-to-date review of the epidemiological evidence linking leukocyte TL (LTL) with PC risk. We searched MEDLINE, Embase, and the Cochrane Library databases for all published studies on LTL and PC risk, up to May 2017. Five studies were identified for review: 4 nested case-control studies and 1 retrospective case-control study. Two studies found opposite associations between LTL and PC risk: 1 found a dose-response positive association and the other found a dose-response inverse association. Two studies also found a "U-shaped" association, whereas another reported a weak nonlinear relationship. We offer potential reasons for the conflicting findings including variation in study design, biospecimen characteristics, and differences in interlaboratory measurements of TL. Future studies should carefully control for risk factors of PC that are associated also with telomere attrition and investigate the role of genetic variation in TL maintenance.
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In the United States, PC is projected to become the second leading cause of cancer death by 2030. 2 The firmly established risk factors for PC include tobacco smoking, preexisting diabetes mellitus, chronic pancreatitis, obesity, and non-O blood type.
3-5 However, the molecular processes by which these risk factors influence pancreatic carcinogenesis are not clear. It is postulated that some of these factors (eg, tobacco smoking, diabetes, and obesity) modulate PC risk by accelerating the shortening of telomeres or telomere length (TL), 6 ,7 the noncoding DNA sequence repeats at the ends of eukaryotic chromosomes that protect chromosomal composition from degradation and maintain chromosomal stability during cell replication. [8] [9] [10] Findings from studies that have investigated the association between peripheral blood leukocyte TL (LTL) and PC risk have been mixed (reviewed in Duell 11 ). However, these studies differ substantially in methods, design, and study population characteristics. Thus, despite inconsistent findings, it remains plausible that LTL may represent a comprehensive biological marker of exposure to risk factors of PC. A better understanding of how TL influences pancreatic carcinogenesis would potentially lead to more effective risk prevention and intervention strategies to reduce incidence and improve outcomes for this deadly malignancy.
Recent data from 2 large prospective studies on the association between peripheral blood LTL and PC risk 12, 13 and from studies relating genetically inferred TL to PC risk 14, 15 necessitate a deeper review of the evidence linking TL with PC risk. We present a focused discussion on the structure and function of TL, its suggested role in tumor suppression, and carcinogenesis hypotheses for critically short TL. We next provide an overview of reported associations between TL and overall cancer risk from an updated review of publications on the association between LTL and PC risk. Finally, we discuss potential reasons for variation in study findings and offer suggestions to guide future telomere research in PC.
TELOMERE BIOLOGY AND IMPLICATIONS FOR CANCER
Telomeres, the protective DNA tandem repeats (TTAGGG) and DNA binding proteins (shelterin) that cap the ends of linear chromosomes, are essential for maintaining genomic stability. 8 The nucleoprotein telomere complex is catalyzed by the telomerase enzyme 9 and involves the TERC gene that encodes the RNA template for the repetitive DNA sequence repeats, a reverse transcriptase subunit (TERT), and the shelterin proteins (eg, TRF1, TRF2, POT1, TIN2, TPP1, and Rap1), which attach the DNA sequence repeats to chromosome ends and regulate telomere maintenance. 10, [16] [17] [18] The main functions of telomeres are to protect chromosomal material from degradation, prevent chromosomal end-to-end fusion, and ensure proper segregation of chromosomes during cell division. 8 In humans, TLs range between 10 and 16.4 kilobase pairs (kbp) at birth [18] [19] [20] but decrease by roughly 50 to 100 base pairs with each cell division owing to incomplete replication by DNA polymerases. 21, 22 Thus, TL decreases throughout a person's life course and is thought to be a marker of biological age. 10, 23, 24 In addition to aging, conditions that promote chronic inflammation (eg, diabetes and obesity) and oxidative stress (eg, tobacco smoking, exposure to ionizing radiation, and habitually low antioxidant intake) contribute further to telomere attrition. [25] [26] [27] [28] Although TLs vary across human tissues, there is far greater variation in TL between individuals than between tissues of the same individual. 19, 29, 30 In leukocytes, an estimated minimum TL of 3.81 kbp is necessary for fully functional telomeres, 10, 31 whereas in germ cells, TLs that are less than 4 kbp are thought to compromise chromosomal integrity. 32 Cells with critically short or dysfunctional telomeres are highly unstable and prone to genomic aberration, increasing cancer risk. 33 The recognition of such cells with telomere dysfunction by immune effector cells triggers cellular damage responses, such as the activation of p53, pRB, ATM, RAD17, and p16
INK4a pathways, which may avert proliferation of potential cancer cells through cellular senescence or apoptosis. [32] [33] [34] [35] [36] [37] Two main hypotheses have emerged on how cells with critically short TL may influence cancer risk. The first postulates that although a majority of cells with extremely short telomeres undergo cellular senescence or apoptosis, on rare occasions, some cells with critically short telomeres evade both mechanisms and undergo uncontrolled proliferation, a hallmark of tumorigenesis. [32] [33] [34] The second posits that although senescent cells lack the ability to proliferate, they remain metabolically active for many years and secret procarcinogenic substances, such as inflammatory cytokines (eg, IL6 and IL8), growth factors, and metalloproteases. 32, 38, 39 Therefore, the accumulation of telomererelated senescent cells may promote a microenvironment that favors carcinogenesis. 40 
TELOMERE LENGTH AND CANCER RISK
It has been suggested that lifestyle factors, such as cigarette smoking, [41] [42] [43] [44] obesity, 28, 41, 45 and physical inactivity, [46] [47] [48] [49] and health states, such as diabetes and insulin resistance, 27, 50 which have been associated with increased cancer risk, may function through a mechanism of shortening of TL. 10, 51 Many studies have investigated the association between LTL and cancer risk, and these have generally indicated that having short LTL may increase risk. 40, [52] [53] [54] [55] [56] [57] The earliest, most comprehensive epidemiological report linking TL with cancer risk was by Wu et al 53 in 2003. They examined the association between peripheral blood lymphocyte TL and cancer risk in a pooled analysis of individual-level data from 4 studies that included 92 head and neck cancers, 135 bladder cancers, 54 lung cancers, and 32 renal cell carcinomas with equal numbers of controls for each cancer type matched on age, sex, and ethnicity. 53 They found that having short TL was associated with increased risk of head and neck cancer. Compared with the fourth quartile category of TL (representing the longest TL), odds ratios (ORs) and 95% confidence intervals (CIs) for decreasing quartiles of TL in relation to head and neck cancer risk were 0.84 (95% CI, 0.36-1.97), 1.77 (95% CI, 0.72-4.36), and 5.11 (95% CI, 1.90-13.77). In a combined analysis of tobacco-related cancers (lung, bladder, and renal cell carcinomas), they observed an increased risk among individuals with short TL, with ORs (95% CIs) for decreasing quartiles of TL of 1.06 (1.90-8.68), 5.08 (2.40-10.75), and 4.41 (2.10-9.28). 53 In general, there is strong evidence for an inverse association between TL and risk of gastric, [54] [55] [56] [57] bladder, 43, 53, 58 ovarian, 56, 59 and esophageal 60,61 cancers, whereas reports from studies on breast, colorectal, lung, and non-Hodgkin lymphoma have varied considerably, and most studies on melanoma, prostate, and endometrial cancers show a null association. 40, 52 Three overlapping meta-analyses have examined the association between TL and cancer risk. 52, 62, 63 The first meta-analysis included 11,255 cancer cases and 13,101 controls from 21 studies published up to November 2010 62 and found increased overall cancer risk among individuals with short telomeres (OR, 1.35; 95% CI, 1.14-1.60; < median vs ≥ median TL), with evidence of heterogeneity between studies (P heterogeneity < 0.001). In separate analyses by cancer type, they found that short telomeres (< median) were associated with increased risk of bladder cancer (OR, 1.84; 95% CI, 1.38-2.44; P heterogeneity = 0.88), lung cancer (OR, 2.39; 95% CI, 1.18-4.88; P heterogeneity = 0.88), and smoking-related cancers (OR, 2.25; 95% CI,1.83-2.78; P heterogeneity = 0.009), but not breast cancer. Short TL was also associated with an increased risk of cancers of the digestive tract: stomach, esophagus and colon, (OR, 1.69; 95% CI, 1.53-1.87; P heterogeneity = 0.88) and cancers of the urogenital system: bladder, kidney, and prostate, (OR, 1.73; 95% CI, 1.12-2.67; P heterogeneity = 0.88). 62 The second meta-analysis included 27 studies published between August 2003 and August 2010. 52 The authors reported that the OR for overall cancer risk comparing the longest TL quartile with the shortest quartile was 1.96 (95% CI, 1.37-2.81; P heterogeneity < 0.001), and there was a stronger association among the 16 retrospective studies (OR, 2.90; 95% CI, 1.75-4.80; P heterogeneity < 0.0001), but no association among the 11 prospective studies (OR, 1.16; 95% CI, 0.87-1.54; P heterogeneity = 0.32). 52 The third meta-analysis included 51 studies published between August 2003 and September 2015 and found a nonsignificant increased overall cancer risk associated with short TL (OR, 1.10; 95% CI, 0.98-1.23; P heterogeneity < 0. 0001). However, there was evidence for an association between short TL and gastrointestinal cancers (OR, 1.62; 95% CI, 1.33-1.97; P heterogeneity < 0.0001) and head and neck cancers (OR, 1.86; 95% CI, 1.23-2.82; P heterogeneity < 0.02). 63 
ASSOCIATION BETWEEN LTL AND PC RISK
A thorough search of MEDLINE, Embase, and the Cochrane Library databases using the search terms "telomere length" OR "telomeres" OR "telomere" AND "pancreatic cancer" OR "pancreatic adenocarcinoma" OR "pancreatic ductal adenocarcinoma" OR "pancreas" OR "pancreatic" showed that as of May 26, 2017, 5 epidemiological studies have been published on association between LTL and PC risk. 6, 7, 12, 13, 64 Three reported a nonlinear or U-shaped association, 6,12,64 1 reported a linear positive association, 64 and another reported a linear inverse association 13 ; details are provided in Table 1 . The first study was a 2012 clinic-based case-control study that consisted of 499 rapidly ascertained PC cases and 963 noncancer control patients frequency-matched on age, sex, and state/region of residence. 6 In that study, Skinner et al used generalized additive logistic regression models treating TL as a continuous variable and observed a U-shaped association, such that individuals with extremely short TL (shortest 1%) and those with extremely long TL (longest 10%) were both found to have an increased risk of PC. 6 When they used the median TL among controls as the reference category, they found an increased risk among those in the 1st to 40th percentiles of TL, decreased risk among those between the 60th and 90th percentiles, and a trend toward increased risk among those in the 99th to 100th percentiles of TL based on distribution among controls (Table 1 ). In 2013, Lynch et al 7 reported on a nested case-control study conducted among heavy Finnish male smokers in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. The study, which included 193 incident PC cases and 660 controls matched on date of birth (±5 years), 7 showed a dose-response positive association between longer TL and PC risk, with an OR of 1.58 (95% CI, 1.1.02-2.46) in the highest versus the lowest quartile and a significant linear trend across quartiles (P trend = 0.003). In 2014, Campa et al examined the association between LTL and PC by pooling individual-level data from 10 cohorts in the European Prospective Investigation into Cancer and Nutrition study. 64 Their study included 331 cases and 331 controls matched on age, sex, and country of origin, and they did not find an association between TL and PC risk when using quartiles of TL-based distribution among controls (OR, 1.38; 95% CI, 0.80-2.41; highest vs lowest quartile). However, when modeling TL as a continuous variable, they found a modest positive association between longer TL and PC risk (OR, 1.13; 95% CI, 1.01-1.27). Further, analysis by cubic In 2016, Bao et al 13 also examined the association between LTL and PC in a pooled analysis of 5 protective cohort studies consisting of 386 cases and 896 controls. These investigators found that short LTL was associated with increased PC risk (OR, 1.72; 95% CI, 1.07-2.78; lowest vs highest quintile, P trend = 0.048). The results from a cubic spline regression were consistent with a linear inverse association between longer TL and PC risk (P nonlinearity > 0.05). 13 In addition, in 2016, Zhang et al 12 examined the association between LTL and PC risk in a population-based nested case-control study of 900 cases and 900 controls in Liaoning, China, and reported a U-shaped association. Using the third quartile as the reference category, they found an increased risk of PC among individuals in the lowest quartile, representing the shortest TL category (OR, 3.10; 95% CI, 1.84-5.21), and an increased risk among those in the highest quartile, representing the longest TL category (OR, 1.49; 95% CI, 1.11-2.00). 12 The relationship between measured LTL and PC therefore remains inconclusive.
Possible Reasons for Inconsistent Results
The mixed findings on the LTL and PC association can be attributed to many factors, including differences in the studied populations, variation in study design, differences in the time between blood collection and the diagnosis of PC, between-laboratory variability in methods used to measure TL, or confounding by factors known to influence TL. As an example, the nested case-control study by Lynch et al 7 that found a positive association between TL and PC was conducted among Finnish males who smoked at least 5 cigarettes per day. 7 By comparison, the nested case-control study by Bao et al 13 that reported an inverse association was conducted among Americans of European descent, including males (35%) and females (65%), and less than 15% of the study subjects were current smokers. It is plausible that the differences in smoking prevalence and sex may in part explain the discordant findings between these 2 prospective studies. Moreover, 4 of the studies used a nested case-control design and measured TL in prediagnostic peripheral blood leukocytes, 7,12,13,64 whereas 1 was a clinic-based retrospective case-control study that measured TL in postdiagnostic blood samples. 6 Even findings from the 4 prospective studies that used prediagnostic blood samples are contradictory, and only 2 of these studies 7, 13 provided data on the median time between blood collection and the diagnosis of PC. Bao et al found no difference in the association between LTL and PC when they performed a stratified analysis by the median time between blood collection and the diagnosis of PC (<6.7 vs ≥6.7 years). 13 Lynch et al did not stratify by the median time between blood collection and diagnosis (6.3 years); however, when stratified by years of follow-up, they found that the association between long TL and increased risk of PC was restricted to cases diagnosed within 5 years of enrollment. 7 This suggests reverse causation-the idea possibility that cancer may use telomere lengthening mechanisms to evade apoptosis and senescence, leading to uncontrolled proliferation of cancer and the accumulation of gene mutations. [32] [33] [34] The differential findings could also be due to interlaboratory variation in the methods used to measure TL. 11 Most of the studies used single quantitative real-time polymerase chain reaction (qPCR) 65 to measure LTL, 6, 12, 13, 64 only Lynch et al 7 used monochrome multiplex qPCR (MMqPCR). 7 Even among studies that used qPCR, differences in the DNA purity of blood samples or in the methods used to identify, quantify, or normalize the telomeric sequence repeats may affect TL measurements between studies. 66, 67 Indeed, Martin-Ruiz et al 68 observed 40% interlaboratory variation in TL measurement when qPCR was used. As described in detail by Cawthon, 69 multiplexing the qPCR method (ie, MMqPCR) is a better approach to measure TL because it is not affected by differences in the amount of DNA used to estimate the ratio of telomere (T) signals to single-copy gene (S) signals (ie, T/S ratio; the standard measure of relative TL). Monochrome multiplex qPCR has also been found to reduce measurement error and increase throughput. 69 Other methods of telomere measurement, such as telomere restriction fragment (TRF) length, single TL analysis, and quantitative fluorescence in situ hybridization, have been described 66, 67 but are not often used in large epidemiological studies because they tend to be labor intensive and time consuming. 66 The discrepancies in study findings may be due also to poor control of confounding factors, particularly tobacco smoking, diabetes mellitus, and obesity. Tobacco smoking is estimated to account for up to 25% of all PCs, 3 and smoking accelerates TL shortening. 41, 43, 44, 49 Indeed, Valdes et al 41 reported a doseresponse association between pack-years of tobacco smoking and TL shortening, such that every 1 pack-year of smoking history was found to be associated with a 5-base pair reduction in LTL. Mirabello et al 44 also observed a significant inverse association between smoking and LTL among both healthy controls and patients with prostate cancer. Diabetes mellitus is also a firmly established risk factor for PC, 4 and studies have consistently shown that LTLs are shorter among diabetics compared with nondiabetes. [70] [71] [72] [73] Obesity and physical inactivity, known risk factors for PC, have all been associated with TL shortening. 28, 41, [45] [46] [47] [48] [49] Poor measurement of these PC risk factors would residually confound the association between TL and PC. Most existing studies on TL and PC risk adjusted for smoking status (ie, never, former, and current). 6, 12, 13, 64 However, it is well known that PC risk increases with smoking dose and duration, 74, 75 and the risk among former smokers approaches that of never smokers after about 15 years of smoking cessation. [74] [75] [76] Thus, adjusting for pack-years of smoking among current smokers and the duration of smoking cessation among former smokers may more adequately control for confounding by smoking. Similarly, adjusting for insulin resistance (a marker of metabolic perturbations that influence TL 27, 77 ) as opposed to self-reported history of diabetes, and adjusting for measured usual adult body mass index (BMI) instead of self-reported BMI, may help clarify the association between TL and PC risk.
ROLE OF GENETIC VARIATION IN TELOMERE MAINTENANCE GENES
As high as 80% of individual differences in TL are attributable to germline variation in telomere-related genes. 10 In view of the conflicting findings from studies involving measured LTL, Antwi et al 14 examined associations between genetically predicted TL and PC risk as a means of overcoming interlaboratory variation in TL measurement and concerns of reverse causation. They computed genetic risk scores involving 8 polymorphisms that were previously associated with interindividual differences in LTL in genome-wide association studies. The study, which included 1500 incident PC cases and 1499 noncancer controls, found no association between genetically predicted TL and PC.
14 Indeed, they found that 1 short telomere-related allele (rs10936599, T) was associated with a lower PC risk, whereas another short telomere-related allele (rs2736100, A) was associated with an increased PC risk. 14 Haycock et al 15 have also reported a null association between genetic markers that determine TL and PC risk in a pooled analysis of genome-wide association studies data that included 5105 PC cases and 8739 controls. However, no study has yet examined whether the association between measured TL and PC risk is modulated by individual variation in telomere maintenance genes (eg, TRC, TERT, TRF1, TRF2, POT1, and Rap1). Because polymorphic variants generally have modest effects, their impact may become more noticeable in the presence of relevant factors. 78, 79 Delineating the potential interactive effect of variation in telomere-related genes and host TL on the risk of PC may help further clarify telomere dynamics in pancreas carcinogenesis. Moreover, it has been suggested that SURVIVIN, a gene known to inhibit apoptosis and enhance telomerase activity by upregulating TERT and found to be overexpressed in patients with PC compared with healthy controls, [80] [81] [82] may modify the association between TL and PC risk. To our knowledge, no study has examined the relationship between SURVIVIN expression in blood or tumor tissue relative to TL in the respective media. Because SURVIVIN promotes telomere lengthening through the activation of telomerase (the enzyme responsible for the elongation of TL), investigations into how SURVIVIN expression or how inherited mutations in SURVIVIN may influence TL would help further elucidate the telomere-PC risk dynamics. Examining gene-gene interactions in the SURVIVIN and the TERT signaling pathways in relation to TL and PC risk may also help better understand the role of telomeres and their influencers in PC.
FUTURE DIRECTIONS
Epidemiological studies examining the association between TL and PC risk have universally relied on peripheral blood LTL as a surrogate for the overall telomere status of an individual. Many studies have reported significant variation in TL across tissues of the same individual [83] [84] [85] [86] ; thus, LTL may not reflect TL in pancreatic tissue. Studies must investigate the intraindividual correlation of TL in leukocytes and matching tumors of PC patients and between leukocytes and matching pancreatic tissue of noncancer individuals to determine the appropriateness of LTL to estimate PC risk. Pancreatic tissue-based studies have reported shorter TL in pancreatic tumors compared with adjacent normal tissue or normal-normal tissue (ie, pancreatic tissue from noncancer patients). [87] [88] [89] Hashimoto et al examined the temporal sequence of TL progression in pancreatic carcinogenesis and found progressive loss of TL during the transition of intraductal papillary mucinous neoplasm (IPMN) from adenoma IPMN to borderline IPMN lesions and to carcinoma in situ IPMN, 87 indicating that telomere shortening precedes the malignant transformation of precancerous somatic cells. A similar finding was reported by Matsuda et al. 89 It is plausible that the temporal changes in TL of pancreatic tissue could have also occurred in the leukocytes of patients who later developed PC. Although the timing of telomere dysfunction in the leukocytes of PC patients is unknown, it could be determined in longitudinal studies with multiple measurements of TL at stages in life that are most relevant to carcinogenesis. Determining the critical point of change in LTL among individuals who later developed PC would facilitate the development of a telomere-based early detection model for PC.
Of the 5 studies relating LTL to PC risk, 4 6,12,13,64 measured TL using the qPCR assay. 65 The precision of the qPCR assay has been questioned, 66, 67 given that it is affected by variation in the amount of DNA used to amplify the telomere signal (T) versus the single gene signal (S) wells. An improved version of the qPCR assay (ie, MMqPCR) that addresses issues relating to differences in DNA quantity in each well has been introduced and could help improve the accuracy of telomere measurement across studies. 69 Other methods, such as the Southern blot analysis of TRFs, quantitative fluorescence in situ hybridization, and single TL analysis, have also been used in telomere research, but these are not generally well suited for large epidemiological studies because they are not high throughput. 66 Furthermore, TL tends to differ in subpopulations of leukocytes; B-cell lymphocytes have longer TLs than T-cell or natural killer cell lymphocytes. [90] [91] [92] Studies are necessary to determine the yield of each leukocyte subtype needed for optimal TL measurement in leukocytes. However, sampling leukocytes with more than 80% B-cell lymphocytes or isolating B-cell lymphocytes only for telomere measurement may be the most informative method. DNA extraction methods also affect comparability of TL measurement between studies. 93, 94 Standardizing DNA extraction for telomere measurement between studies and adopting the high-throughput MMqPCR method instead of the qPCR method widely used in epidemiological research may help minimize variability in the measurement of TL between studies. 66 Because TL is determined partly by interindividual germline variation, age (a measure of cellular replicative history), environmental exposures (eg, smoking), and chronic conditions (eg, diabetes) are associated with PC risk; thus, it is important that studies examining the association between TL and PC adequately control for potential confounding effects of these factors. To reduce confounding by tobacco smoking history, studies must consider adjusting for pack-years of smoking among current smokers and the duration of smoking cessation among former smokers. Moreover, because PC is often associated with significant weight loss and patients often have experienced substantial weight loss before clinical diagnosis of the disease, 95 it would be of interest for studies to use measured usual adult weight and height to calculate and adjust for BMI, rather than the frequently used self-reported BMI or measured BMI at diagnosis. Adjusting for a clinically verified diagnosis of diabetes or insulin resistance would also help to minimize confounding by metabolic disturbances that influence TL. 27, 70 Although studies that have examined the association between genetically predicted TL and PC have reported null findings, 14, 15 an advancement in this area could be the investigation of interactive effects between inherited variation in telomere maintenance and tobacco smoking or personal history of diabetes. Evaluation of the joint effects of known risk factors (ie, diabetes, smoking, or obesity) and TL in relation to the risk of PC also could inform tailored interventions based on genomic profiles to maximize the impact of PC prevention efforts.
In summary, we have presented a focused overview on the association between TL and PC. The data presented here show that the association between LTL and PC is not completely clear. However, the most comprehensive study involving pooled data from 5 prospective cohorts points to a dose-response increase in PC risk among individuals with short LTL. 13 Possible reasons for the differences in study findings have been discussed. Suggestions range from choice of study design, choice of technology for the measurement of LTL in large epidemiological studies, and methods for controlling for confounding by extraneous factors. We propose approaches to address gaps in knowledge to guide future research regarding the association of between PC and TL.
